Efecto de la vitamina K oral e intramuscular sobre los factores II, VII, IX, X y PIVKA II en el recién nacidohasta los 60 días de edad: Relación con la alimentación

par Arteaga-Vizcaíno,Melvis, Espinoza Holguín,Maurín, Torres Guerra,Enrique, Diez-Ewald,María, Quintero,Jesús, Vizcaíno,Gilberto, Estévez,Jesús, Fernández,Nelson
Publié 2001

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention

par Marek Koziński, Joanna Rejszel-Baranowska, Elżbieta Młodawska, Jolanta M. Siller-Matula, Anna Tomaszuk-Kazberuk
Publié 2020

Belgian Consensus Recommendations to Prevent Vitamin K Deficiency Bleeding in the Term and Preterm Infant

par Simon Fiesack, Anne Smits, Maissa Rayyan, Karel Allegaert, Philippe Alliet, Wim Arts, An Bael, Luc Cornette, Ann De Guchtenaere, Nele De Mulder, Isabel George, Elisabeth Henrion, Kirsten Keiren, Nathalie Kreins, Marc Raes, Pierre Philippet, Bart Van Overmeire, Myriam Van Winckel, Vinciane Vlieghe, Yvan Vandenplas, on behalf of the Groups
Publié 2021

Development ofafoodfrequency questionnaire to determine vitamin k intake in anticoagulated patients: a pilot study

par Dias Mendonça,Dayana, Zuchinali,Priccila, Corrêa Souza,Gabriela
Publié 2018

Eficacia y seguridad del tratamiento anticoagulante oral con antagonistas de vitamina K en pacientes con prótesis valvulares cardíacas

par Marín,Arnaldo, Neira,Víctor, Aizman,Andrés, Paredes,Alejandro, Palma,Soledad, Ruiz,María, Revello,Javier, Zvaighaft,Samuel, Cea,Constanza, Corbalán,Ramón
Publié 2014

Influence of vitamin K2 on lipid precursors of inflammation and fatty acids pathway activities in HepG2 cells

par Adrian Kołakowski, Piotr Franciszek Kurzyna, Wiktor Bzdęga, Hubert Żywno, Ewa Harasim-Symbor, Adrian Chabowski, Karolina Konstantynowicz-Nowicka
Publié 2021

Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians

par Foody JM
Publié 2017

Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis

par Clara Bonanad, Sergio García-Blas, Javier Torres Llergo, Rosa Fernández-Olmo, Pablo Díez-Villanueva, Albert Ariza-Solé, Manuel Martínez-Sellés, Sergio Raposeiras, Ana Ayesta, Vicente Bertomeu-González, Francisco Tarazona Santabalbina, Lorenzo Facila, David Vivas, Ana Gabaldón-Pérez, Vicente Bodi, Julio Nuñez, Alberto Cordero
Publié 2021

Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis

par Suksomboon N, Poolsup N, Darli Ko Ko H
Publié 2017

Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation

par Chang CC, Liou HH, Wu CL, Chang CB, Chang YJ, Chiu PF, Huang CH
Publié 2013

Vitamin K1 As A Potential Molecule For Reducing Single-Walled Carbon Nanotubes-Stimulated α-Synuclein Structural Changes And Cytotoxicity

par Naskhi A, Jabbari S, Othman GQ, Aziz FM, Salihi A, Sharifi M, Sari S, Akhtari K, Abdulqadir SZ, Alasady AAB, Abou-Zied OK, Hasan A, Falahati M
Publié 2019

Vitamin K2 supplementation and the progression of abdominal aortic calcification in dialysis patients

par Shoya Oyama, Naoki Okamoto, Shigehisa Koide, Hiroki Hayashi, Shigeru Nakai, Kazuo Takahashi, Daijo Inaguma, Midori Hasegawa, Hiroshi Toyama, Satoshi Sugiyama, Yukio Yuzawa, Naotake Tsuboi
Publié 2021

Effects of MK-7 Supplementation on Glycemic Status, Anthropometric Indices and Lipid Profile in Patients with Type 2 Diabetes: A Randomized Controlled Trial

par Karamzad N, Faraji E, Adeli S, Carson‐Chahhoud K, Azizi S, Pourghassem Gargari B
Publié 2020

Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies

par Fuwei Liu, Zixuan Xu, Jun Luo, Peng Yu, Jianyong Ma, Ping Yuan, Wengen Zhu
Publié 2021

Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants

par Turagam MK, Velagapudi P, Flaker GC
Publié 2015

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

par Eve Cariou, Eve Cariou, Kevin Sanchis, Kevin Sanchis, Khailène Rguez, Khailène Rguez, Virginie Blanchard, Virginie Blanchard, Virginie Blanchard, Virginie Blanchard, Stephanie Cazalbou, Stephanie Cazalbou, Pauline Fournier, Pauline Fournier, Antoine Huart, Murielle Roussel, Pascal Cintas, Michel Galinier, Michel Galinier, Michel Galinier, Didier Carrié, Didier Carrié, Didier Carrié, Philippe Maury, Philippe Maury, Yoan Lavie-Badie, Yoan Lavie-Badie, Yoan Lavie-Badie, Yoan Lavie-Badie, Olivier Lairez, Olivier Lairez, Olivier Lairez, Olivier Lairez
Publié 2021

ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication

par Bingfeng Liang, Dangxia Zhou
Publié 2021

Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion

par Pedro Luis Cepas-Guillen, Eduardo Flores-Umanzor, Ander Regueiro, Salvatore Brugaletta, Cristina Ibañez, Laura Sanchis, Marta Sitges, Josep Rodés-Cabau, Manel Sabaté, Xavier Freixa
Publié 2021

Vitamins as Possible Cancer Biomarkers: Significance and Limitations

par Sascha Venturelli, Christian Leischner, Thomas Helling, Markus Burkard, Luigi Marongiu
Publié 2021

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

par Gilda Denise Zielinski, Nienke vanRein, Martina Teichert, Frederikus A. Klok, Frits R. Rosendaal, Felix J. M. van derMeer, Menno V. Huisman, Suzanne C. Cannegieter, Willem M. Lijfering
Publié 2020